Trial Details
COMPLETEDBasic Information
| Clinical ID | c1962 |
|---|---|
| Identifier | NCT02302404 |
| Trial Title | A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | DRUG: GSK2982772 solution; DRUG: GSK2982772 capsule; DRUG: Placebo solution; DRUG: Placebo capsule |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Cambridge |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | MALE |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2015-01-06 |
|---|---|
| Primary Completion Date | 2016-03-05 |
| Completion Date | 2016-03-05 |